We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
TECARINI; TELMISARTAN/AMLODIPINE MYLAN (Alphapharm Pty Ltd)
Product name
TECARINI; TELMISARTAN/AMLODIPINE MYLAN
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
162 (255 working days)
Active ingredients
telmisartan; amlodipine besilate
Registration type
New generic medicine
Indication
TECARINI; TELMISARTAN/AMLODIPINE MYLAN (film-coated tablet) is approved for the treatment of hypertension. Treatment should not be initiated with this fixed-dose combination (see dosage and administration).